• Explore /
  • Poster
  • / TALENTop: A multicenter, randomized study evaluating the efficacy and safety of hepatic resection for selected hepatocellular carcinoma with macrovascular invasion after initial atezolizumab plus bevacizumab treatment.

TALENTop: A multicenter, randomized study evaluating the efficacy and safety of hepatic resection for selected hepatocellular carcinoma with macrovascular invasion after initial atezolizumab plus bevacizumab treatment.

Abstract Poster

Authors

null

Hui-Chuan Sun

Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China

Hui-Chuan Sun , Feng Shen , Lianxin Liu , Zhi-Yong Huang , Tianqiang Song , Bang-De Xiang , Xueli Bai , Xiaodong Zhu , Jian Zhou , Jia Fan , Ming Kuang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT04649489

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4175)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4175

Abstract #

TPS4175

Poster Bd #

153a

Abstract Disclosures

Similar Posters

First Author: Valeriy Vladimirovich Breder

First Author: Richard S. Finn

First Author: Han Chong Toh

First Author: Stacey Stein